Skip to main content
Clinical Trials/ISRCTN74447767
ISRCTN74447767
Completed
未知

Effectiveness of parenting training in mothers with a borderline personality disorder: a multiple baseline design

GGZ Noord-Holland-Noord0 sites10 target enrollmentMarch 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Borderline personality disorder
Sponsor
GGZ Noord-Holland-Noord
Enrollment
10
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2022
End Date
September 25, 2021
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
GGZ Noord-Holland-Noord

Eligibility Criteria

Inclusion Criteria

  • 1\. A full diagnosis of BPD: meeting Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM\-5\) criteria for BPD measured by a SCID\-P\-5, a structured clinical interview (Arntz et al., 2017\)
  • 2\. Aged above 18 years
  • 3\. The primary caregiver to at least one child under the age of 8 years at the start of the group; whereby the acute welfare of the child was not endangered
  • 4\. Dutch speaking; able to comprehend Dutch at a level sufficient to complete self\-report instruments, the assignments, the group training and individual sessions
  • 5\. Willing and able to commit to attending a 2\-hour group once a week for 12 weeks, all measurements and 45 minutes individual session every other week

Exclusion Criteria

  • 1\. Lifetime psychosis or bipolar disorder type I
  • 2\. Insufficient cognitive capacity to comprehend the topics being discussed; screened by the SCIL (screener for intelligence and learning difficulties) with a cut\-off score of 19 (Kaal et al. 2015\)
  • 3\. Significant substance abuse that would have an impact on group functioning; as per clinical judgement following discussion with the research team
  • 4\. Start of new medication within 3 months before the start of this study
  • Participants will not be excluded due to concurrent treatment (pharmacological or non\-pharmacological)

Outcomes

Primary Outcomes

Not specified

Similar Trials